Côte d'Ivoire vs Mexico: Adults (ages 15+) and children (0-14 years) living with HIV
Côte d'Ivoire
410,000
in 2024
Mexico
400,000
in 2024
Côte d'Ivoire rank
16th
Mexico rank
17th
Adults (ages 15+) and children (0-14 years) living with HIV over time
- Côte d'Ivoire
- Mexico
How they compare
Côte d'Ivoire currently reports 410,000 against 400,000 in Mexico, a difference of 10,000.
Across all 35 years both countries report, Côte d'Ivoire has been ahead every year.
Côte d'Ivoire ranks 16th and Mexico ranks 17th of 152 countries.
Côte d'Ivoire has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 591,000 | 67,400 | 523,600 | Côte d'Ivoire |
| 2000s | 636,000 | 153,000 | 483,000 | Côte d'Ivoire |
| 2010s | 476,000 | 268,000 | 208,000 | Côte d'Ivoire |
| 2020s | 418,000 | 368,000 | 50,000 | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (0-14 years) living with hiv, Côte d'Ivoire or Mexico?
- Côte d'Ivoire, at 410,000 against 400,000 in Mexico as of 2024.
- What is the difference in adults (ages 15+) and children (0-14 years) living with hiv between Côte d'Ivoire and Mexico?
- 10,000, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Mexico?
- 35 years are reported by both, from 1990 to 2024.
- How do Côte d'Ivoire and Mexico rank globally for adults (ages 15+) and children (0-14 years) living with hiv?
- Côte d'Ivoire ranks 16th and Mexico ranks 17th of 152 countries.
- Where does this data come from?
- UNAIDS estimates, published as Adults (ages 15+) and children (0-14 years) living with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Adults and children living with HIV refers to the number of people ages 0-49 (adult ages 15-49 and children ages 0-14) who are infected with HIV.